
| ID | 71364 |
| フルテキストURL | |
| 著者 |
Oguni, Kohei
Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Akazawa, Hidemasa
Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Fukushima, Shinnosuke
Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Suzuki, Yasuhiro
Emergency and Critical Care Center, Kurashiki Central Hospital
Kanai, Katsuki
Department of Emergency and Critical Care Medicine, Shimane Prefectural Central Hospital
Haruki, Yuto
Department of Pharmacy, Tsuyama Chuo Hospital
Mukuda, Kengo
Department of Infectious Diseases and General Internal Medicine, Tottori Prefectural Central Hospital
Matsumoto, Hidemaru
Department of Pharmacy, Japanese Red Cross Society Himeji Hospital
Fujihara, Tatsuya
Department of General Internal Medicine, Masuda Red-Cross Hospital
Hagiya, Hideharu
Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
researchmap
|
| 抄録 | Background. Invasive group B Streptococcus (GBS) infection in nonpregnant adults is increasing, particularly among older adults and those with underlying comorbidities. However, multicenter data on prognostic factors for adult GBS bacteremia in Japan remain limited.
Methods. We conducted a multicenter retrospective observational cohort study of adults with GBS bacteremia at 7 hospitals in western Japan between 2015 and 2024. Variables analyzed included clinical characteristics, infection sites, microbiological characteristics, and antimicrobial susceptibility profiles. Univariable and multivariable logistic regression analyses were performed to identify factors associated with 30-day mortality. Results. A total of 442 patients were included. Median age [interquartile range] was 75 [64–84] years, and 83.0% had at least 1 comorbidity. The overall 30-day all-cause mortality for GBS bacteremia was 9.3% (41/442), which rose to 39.3% (11/28) among patients with streptococcal toxic shock syndrome (STSS). In multivariable analysis, STSS was the strongest predictor of death (adjusted odds ratio [aOR], 9.16; 95% confidence interval [CI], 3.28–25.58), followed by immunosuppressive therapy (aOR, 4.62; 95% CI, 1.66–12.86), cirrhosis (aOR, 3.40; 95% CI, 1.23–9.40), respiratory infection (aOR, 3.30; 95% CI, 1.08–10.06), advanced renal dysfunction (aOR, 2.66; 95% CI, 1.09–6.52), and polymicrobial bacteremia (aOR, 2.40; 95% CI, 1.03–5.57), whereas skin and soft tissue infection was associated with lower mortality (aOR, 0.07; 95% CI, 0.01–0.53). Conclusions. Adult GBS bacteremia carries a high burden of short-term mortality, with a wide variety of clinical presentations, necessitating prompt diagnostic and therapeutic intervention. |
| キーワード | bacteremia
group B Streptococcus
invasive group B streptococcal disease
streptococcal toxic shock syndrome
streptococcus agalactiae
|
| 発行日 | 2026-09-29
|
| 出版物タイトル |
Open Forum Infectious Diseases
|
| 巻 | 13巻
|
| 号 | 10号
|
| 出版者 | Oxford University Press (OUP)
|
| 開始ページ | ofag665
|
| ISSN | 2328-8957
|
| 資料タイプ |
学術雑誌論文
|
| 言語 |
英語
|
| OAI-PMH Set |
岡山大学
|
| 著作権者 | © The Author(s) 2026.
|
| 論文のバージョン | publisher
|
| DOI | |
| Web of Science KeyUT | |
| 関連URL | isVersionOf https://doi.org/10.1093/ofid/ofag665
|
| ライセンス | https://creativecommons.org/licenses/by/4.0/
|
| Citation | Kohei Oguni, Hidemasa Akazawa, Shinnosuke Fukushima, Yasuhiro Suzuki, Katsuki Kanai, Yuto Haruki, Kengo Mukuda, Hidemaru Matsumoto, Tatsuya Fujihara, Hideharu Hagiya, Clinical Characteristics and Mortality Predictors of Group B Streptococcus Bacteremia in Adults: A Multicenter Retrospective Cohort Study in Japan, 2015–2024, Open Forum Infectious Diseases, Volume 13, Issue 10, October 2026, ofag665, https://doi.org/10.1093/ofid/ofag665
|